Phase Ⅰ Clinical Study of Anti-CD52 Monoclonal Antibody in NHL and T-PLL
Condition(s):Lymphoma, Non-Hodgkin; Lymphoma, T-CellLast Updated:September 28, 2022Unknown status
Hide Studies Not Open or Pending
Condition(s):Lymphoma, Non-Hodgkin; Lymphoma, T-CellLast Updated:September 28, 2022Unknown status
Condition(s):Overactive BladderLast Updated:January 3, 2018Unknown status
Condition(s):Meningococcal MeningitisLast Updated:June 25, 2015Unknown status
Condition(s):Chronic MigraineLast Updated:January 3, 2018Unknown status
Condition(s):Cerebrovascular AccidentLast Updated:September 26, 2016Completed
Condition(s):Norovirus Infections; Norwalk GastroenteritisLast Updated:June 23, 2023Not yet recruiting
Condition(s):PlagueLast Updated:November 4, 2015Completed
Condition(s):COVID-19 PneumoniaLast Updated:July 22, 2022Active, not recruiting
Condition(s):COVID-19 Pneumonia; Coronavirus InfectionsLast Updated:February 2, 2023Active, not recruiting
Condition(s):Norovirus Infections; Norwalk GastroenteritisLast Updated:October 28, 2022Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.